Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
arylpiperazines
Description:
Arylpiperazines are chemical compounds containing an aryl group attached to a piperazine ring, studied in medicinal chemistry and drug discovery.
Related topics:
Heterocyclic Compound Synthesis and Bioactivity (16%),
Receptor Mechanisms and Signaling (12%),
Computational Drug Discovery Methods (12%),
Neurotransmitter Receptor Influence on Behavior (10%)
OpenAlex ID:
keywords/arylpiperazines
Molecular biology of 5-HT receptors
1994
·
F.G. Boess
, I.L. Martin
·
Neuropharmacology
·
745
Industrial‐Scale Palladium‐Catalyzed Coupling of Aryl Halides and Amines –A Personal Account
2006
·
Stephen L. Buchwald
, Christelle Mauger
, et al.
·
Advanced Synthesis & Catalysis
·
536
Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in Escherichia coli Overexpressing RND Efflux Pumps
2005
·
Jürgen A. Bohnert
, Winfried V. Kern
·
Antimicrobial Agents and Chemotherapy
·
250
Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.
1991
·
D L Murphy
, K P Lesch
, et al.
·
Pharmacological Reviews
·
220
Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?
1989
·
Philippe Schoeffter
, Daniel Hoyer
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
188
Biophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design
2013
·
John A. Christopher
, Jason Brown
, et al.
·
Journal of Medicinal Chemistry
·
180
PDF
Synthesis, Biological Evaluation, and Pharmacophore Generation of New Pyridazinone Derivatives with Affinity toward α1- and α2-Adrenoceptors
2001
·
Roberta Barbaro
, Laura Betti
, et al.
·
Journal of Medicinal Chemistry
·
134
Ruthenium-Complex-Catalyzed N-(Cyclo)alkylation of Aromatic Amines with Diols. Selective Synthesis of N-(ω-Hydroxyalkyl)anilines of Type PhNH(CH2)nOH and of Some Bioactive Arylpiperazines
1998
·
Rob A. T. M. Abbenhuis
, Jaap Boersma
, et al.
·
The Journal of Organic Chemistry
·
116
GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivo
1986
·
Jean-Jacques Bonnet
, Jean Costentin
·
European Journal of Pharmacology
·
109
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands
1988
·
Richard A. Glennon
, Noreen A. Naiman
, et al.
·
Journal of Medicinal Chemistry
·
106
Homology Modeling of the Serotonin 5-HT1AReceptor Using Automated Docking of Bioactive Compounds with Defined Geometry
2005
·
Mateusz Nowak
, Marcin Kołaczkowski
, et al.
·
Journal of Medicinal Chemistry
·
100
The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity
1989
·
James S. New
, William L. Christopher
, et al.
·
Journal of Medicinal Chemistry
·
100
Quinoline- and Isoquinoline-Sulfonamide Analogs of Aripiprazole: Novel Antipsychotic Agents?
2013
·
Pawel Zajdel
, Anna Partyka
, et al.
·
Future Medicinal Chemistry
·
95
Derivatives as 5HT1A Receptor Ligands-Past and Present
2005
·
G. Caliendo
, V. Santagada
, et al.
·
Current Medicinal Chemistry
·
92
5-HT1 and 5-HT2: binding characteristics of some quipazine analogs
1986
·
Richard A. Glennon
, R. M. Slusher
, et al.
·
Journal of Medicinal Chemistry
·
92
Synthesis of arylpiperazines via palladium-catalyzed aromatic amination reaction with unprotected piperazines
1996
·
Shu-Hai Zhao
, Aubry K. Miller
, et al.
·
Tetrahedron Letters
·
91
New 1-Aryl-3-(4-arylpiperazin-1-yl)propane Derivatives, with Dual Action at 5-HT1ASerotonin Receptors and Serotonin Transporter, as a New Class of Antidepressants
2000
·
Javier Martínez-Esparza
, Ana-M. Oficialdegui
, et al.
·
Journal of Medicinal Chemistry
·
79
Receptor-Based Pharmacophores for Serotonin 5-HT7R AntagonistsImplications to Selectivity
2006
·
Marcin Kołaczkowski
, Mateusz Nowak
, et al.
·
Journal of Medicinal Chemistry
·
78
Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 1. Mapping the Central 5-HT3 Receptor Binding Site by Arylpiperazine Derivatives
1998
·
Andrea Cappelli
, Maurizio Anzini
, et al.
·
Journal of Medicinal Chemistry
·
75
Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study
1989
·
Richard A. Glennon
, Abd El-Kader M. Ismaiel
, et al.
·
European Journal of Pharmacology
·
75
Coumarin-piperazine derivatives as biologically active compounds
2019
·
Kinga Ostrowska
·
Saudi Pharmaceutical Journal
·
72
Non-Peptide Glycoprotein IIb/IIIa Antagonists. 11. Design and in Vivo Evaluation of 3,4-Dihydro-1(1H)-isoquinolinone-Based Antagonists and Ethyl Ester Prodrugs
1996
·
John H. Hutchinson
, Jacquelynn J. Cook
, et al.
·
Journal of Medicinal Chemistry
·
70
Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure
2017
·
Dorothee Möller
, Ashutosh Banerjee
, et al.
·
Journal of Medicinal Chemistry
·
68
Novel 5-HT 7 Receptor Inverse Agonists. Synthesis and Molecular Modeling of Arylpiperazine- and 1,2,3,4-Tetrahydroisoquinoline-Based Arylsulfonamides
2004
·
Erik S. Vermeulen
, Marjan van Smeden
, et al.
·
Journal of Medicinal Chemistry
·
68
Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 1. 2-[[4-(o-Methoxyphenyl)piperazin-1-yl]methyl]-1,3- dioxoperhydroimidazo[1,5-a]pyridine: A Selective 5-HT1A Receptor Agonist
1996
·
María L. López-Rodríguez
, M Luisa Rosado
, et al.
·
Journal of Medicinal Chemistry
·
68
Show more works
View as search
Works count:
478
Citation count:
8,803
Year
Topic
Type